Anti-CD3 antibody decreases inflammation and improves outcome in a murine model of Pneumocystis pneumonia

Journal of Immunology

Volumn 184, Issue 1, 2010, Pages 497-502

  Bhagwat, Samir P ^a   Wright, Terry W ^a   Gigliotti, Francis ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIBODY; COTRIMOXAZOLE; ANTIBODY; ANTIINFECTIVE AGENT; CD3 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNE RESPONSE; INFLAMMATION; LUNG FUNCTION; LUNG LAVAGE; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT DURATION; ANIMAL; DISEASE MODEL; IMMUNOLOGY; LYMPHOCYTE DEPLETION; METHODOLOGY; MICROBIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIBODIES; ANTIGENS, CD3; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; INFLAMMATION; LYMPHOCYTE DEPLETION; MICE; PNEUMONIA, PNEUMOCYSTIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 73949144758     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901864     Document Type: Article

References (26)

1. D'Avignon, L. C., C. M. Schofield, and D. R. Hospenthal. 2008. Pneumocystis pneumonia. Semin. Respir. Crit. Care Med. 29: 132-140.
2. varez-Martinez, M. J., A. Moreno, J. M. Miro, M. E. Valls, P. V. Rivas, E. de Lazzari, O. Sued, N. Benito, P. Domingo, E. Ribera, et al. 2008. Pneumocystis jirovecii pneumonia in Spanish HIV-infected patients in the combined anti-retroviral therapy era: prevalence of dihydropteroate synthase mutations and prognostic factors of mortality. Diagn. Microbiol. Infect. Dis. 62: 34-43.
3. Walzer, P. D., H. E. Evans, A. J. Copas, S. G. Edwards, A. D. Grant, and R. F. Miller. 2008. Early predictors of mortality from Pneumocystis jirovecii pneumonia in HIV-infected patients: 1985-2006. Clin. Infect. Dis. 46: 625-633.
4. Bhagwat, S. P., F. Gigliotti, H. Xu, and T. W. Wright. 2006. Contribution of T cell subsets to the pathophysiology of Pneumocystis-related immunorestitution disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 291: L1256-L1266.
5. Gigliotti, F., E. L. Crow, S. P. Bhagwat, and T.W. Wright. 2006. Sensitized CD8+ T cells fail to control organism burden but accelerate the onset of lung injury during Pneumocystis carinii pneumonia. Infect. Immun. 74: 6310-6316.
6. Roths, J. B., and C. L. Sidman. 1992. Both immunity and hyperresponsiveness to Pneumocystis carinii result from transfer of CD4+ but not CD8+ T cells into severe combined immunodeficiency mice. J. Clin. Invest. 90: 673-678.
7. Wright, T. W., C. J. Johnston, A. G. Harmsen, and J. N. Finkelstein. 1999. Chemokine gene expression during Pneumocystis carinii-driven pulmonary inflammation. Infect. Immun. 67: 3452-3460.
8. Wright, T. W., F. Gigliotti, J. N. Finkelstein, J. T. McBride, C. L. An, and A. G. Harmsen. 1999. Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia. J. Clin. Invest. 104: 1307-1317.
9. Wright, T. W., R. H. Notter, Z. Wang, A. G. Harmsen, and F. Gigliotti. 2001. Pulmonary inflammation disrupts surfactant function during Pneumocystis carinii pneumonia. Infect. Immun. 69: 758-764.
10. Wright, T. W., G. S. Pryhuber, P. R. Chess, Z. Wang, R. H. Notter, and F. Gigliotti. 2004. TNF receptor signaling contributes to chemokine secretion, inflammation, and respiratory deficits during Pneumocystis pneumonia. J. Immunol. 172: 2511-2521.
11. Benfield, T. L., J. Vestbo, J. Junge, T. L. Nielsen, A. B. Jensen, and J. D. Lundgren. 1995. Prognostic value of interleukin-8 in AIDS-associated Pneumocystis carinii pneumonia. Am. J. Respir. Crit. Care Med. 151: 1058-1062.
12. Limper, A. H., K. P. Offord, T. F. Smith, andW. J. Martin 2nd. 1989. Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am. Rev. Respir. Dis. 140: 1204-1209.
13. Skerrett, S. J., and D. R. Park. 2001. Anti-inflammatory treatment of acute and chronic pneumonia. Semin. Respir. Infect. 16: 76-84.
14. Shellito, J., V. V. Suzara, W. Blumenfeld, J. M. Beck, H. J. Steger, and T. H. Ermak. 1990. A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. J. Clin. Invest. 85: 1686-1693.
15. Harmsen, A. G., and M. Stankiewicz. 1990. Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice. J. Exp. Med. 172: 937-945.
16. Meissner, N. N., F. E. Lund, S. Han, and A. Harmsen. 2005. CD8 T cell-mediated lung damage in response to the extracellular pathogen pneumocystis is dependent on MHC class I expression by radiation-resistant lung cells. J. Immunol. 175: 8271-8279.
17. Swain, S. D., N. N. Meissner, and A. G. Harmsen. 2006. CD8 T cells modulate CD4 T-cell and eosinophil-mediated pulmonary pathology in pneumocystis pneumonia in B-cell-deficient mice. Am. J. Pathol. 168: 466-475.
18. Leo, O., M. Foo, D. H. Sachs, L. E. Samelson, and J. A. Bluestone. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. U.S.A. 84: 1374-1378.
19. Hirsch, R., J. Archibald, and R. E. Gress. 1991. Differential T cell hyporesponsiveness induced by in vivo administration of intact or F(ab′)2 fragments of anti-CD3 monoclonal antibody. F(ab′)2 fragments induce a selective T helper dysfunction. J. Immunol. 147: 2088-2093.
20. Wang, J., F. Gigliotti, S. Maggirwar, C. Johnston, J. N. Finkelstein, and T. W. Wright. 2005. Pneumocystis carinii activates the NF-kappaB signaling pathway in alveolar epithelial cells. Infect. Immun. 73: 2766-2777.
21. Disney, M. D., R. Stephenson, T. W. Wright, C. G. Haidaris, D. H. Turner, and F. Gigliotti. 2005. Activity of Hoechst 33258 against Pneumocystis carinii f. sp. muris, Candida albicans, and Candida dubliniensis. Antimicrob. Agents Chemother. 49: 1326-1330.
22. Bergmann, K. C., B. Lachmann, and K. Noack. 1984. Lung mechanics in orally immunized mice after aerolized exposure to influenza virus. Respiration 46: 218-221.
23. Amdur, M. O., and J. Mead. 1958. Mechanics of respiration in unanesthetized guinea pigs. Am. J. Physiol. 192: 364-368.
24. Lee, L. H., F. Gigliotti, T. W. Wright, P. J. Simpson-Haidaris, G. A. Weinberg, and C. G. Haidaris. 2000. Molecular characterization of KEX1, a kexin-like protease in mouse Pneumocystis carinii. Gene 242: 141-150.
25. Chatenoud, L. 2003. CD3-specific antibody-induced active tolerance: from bench to bedside. Nat. Rev. Immunol. 3: 123-132.
26. Swain, S. D., T. W. Wright, P. M. Degel, F. Gigliotti, and A. G. Harmsen. 2004. Neither neutrophils nor reactive oxygen species contribute to tissue damage during Pneumocystis pneumonia in mice. Infect. Immun. 72: 5722-5732.